| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -109.47M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VERA returned +43.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -36.3% |
| 1 year | +43.0% |
| 5 years | +119.0% |
| All-time high | $50.64 (Dec 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VERA would be worth today ›No. Vera Therapeutics, Inc. has not paid a dividend in the past 12 months.
Vera Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol VERA.
Vera Therapeutics, Inc. is part of the Healthcare sector.
Vera Therapeutics, Inc. has a market cap of 2.33B USD, based on the latest quote.
Vera Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.